Latest News
- January 30, 2008
- Execution of an Exclusive Patent License and Collaborative Research and Development Agreement with Merck & Co.,Inc. in the Field of Infectious Diseases
- January 25, 2008
- KIPRES Received Approvals for Additional Indication to Relieve Symptoms of Allergic Rhinitis
- December 26, 2007
- KYORIN Obtains Credit Rating from R&I
- October 12, 2007
- Discontinuation of Cooperation on Baynas Marketing for Treatment of Allergic Rhinitis by Kyorin Pharmaceutical Co.,Ltd. and Bayer Yakuhin,Ltd.
- October 2, 2007
- Launch of "KIPRES" Oral Granules 4mg
- September 26, 2007
- Merger between Kyorin Phamaceutical Co.,Ltd. and Nisshin Kyorin Pharmaceutical Co.,Ltd.
- July 31, 2007
- Marketing Approval for "KIPRES" Oral Granules 4mg
- March 10, 2006
- On the Transition to a Holding - Company Structure
- Previous Page
- 5
- 6
- 7
